HOME >> BIOLOGY >> NEWS
UI Study Reveals Important Information About Molecular Defect In Limb Girdle Muscular Dystrophy

IOWA CITY, Iowa -- For the first time ever, University of Iowa researchers have confirmed how a protein complex, when defective, causes limb girdle muscular dystrophy.

This information could help scientists to develop new ways to treat limb girdle forms of muscular dystrophy. Limb girdle varieties affect between one in 20,000 and one in 50,000 individuals.

"We have established a cell culture system that we can use to mimic the defect in limb girdle muscular dystrophy," said Kevin Campbell, Ph.D., UI professor of physiology and biophysics, and neurology, and a Howard Hughes Medical Institute Investigator.

The UI findings appeared in a recent issue of the Journal of Biological Chemistry.

Campbell, along with Kate Holt, Ph.D., a postdoctoral fellow in Campbell's lab, used the cell culture system to find out how the protein complex, called the sarcoglycan complex, forms. The sarcoglycan complex, composed of four distinct transmembrane glycoproteins, is part of the dystrophin-glycoprotein complex, a group of proteins located in muscle cell membranes. The dystrophin-glycoprotein complex is thought to stabilize the membrane against contraction-induced damage. Past studies have shown that mutations to the sarcoglycan complex cause various types of limb girdle muscular dystrophy.

Muscular dystrophy is a group of diseases characterized by hereditary progressive muscle weakness and degeneration. The unifying theme among limb girdle varieties of the disease is the initial involvement of the shoulder and pelvic girdle muscles, with relative sparing of most other muscle groups.

Despite rapid advances regarding the genetic defects that cause limb girdle muscular dystrophy, researchers know little about the molecular defects underlying the disease. Through their cell culture model, Campbell and Holt were able to show that complete assembly of the sarcoglycan complex is dependent on the simultaneous synthesis of all four sarcoglycans. Any mutant sarcogly
'"/>

Contact: Jennifer Cronin
jennifer-cronin@uiowa.edu
319-335-9917
University of Iowa
4-Mar-1999


Page: 1 2

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 25, 2020 , ... ... in partnership with Essex Bio-Technology, a bio-pharmaceutical company specializing in Ophthalmology and ... study of SkQ1 ophthalmic solution in patients with moderate to severe Dry ...
(Date:8/26/2020)... ... ... Modality Solutions, a biopharmaceutical cold chain validation engineering firm, is ... is the most prestigious ranking of the nation’s fastest-growing private companies. Modality Solutions made ... three-year revenue growth of 71 percent. , The Inc. 5000 list represents a ...
(Date:8/21/2020)... ... August 18, 2020 , ... Sentien Biotechnologies, ... that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational ... the treatment of severe COVID-19. Approval of this IND allows Sentien to initiate ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... BEDFORD, Mass. (PRWEB) , ... July 29, 2020 ... ... of highly reliable, solid-state radar transmitter systems that can be configured to drive ... a single controller that can drive one or two switches in a push-pull ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... 200 of the top radiation centers in 16 countries, has reached its 20th ... SDX® is now in routine use at top universities including University of Pennsylvania, ...
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver this new technology ... technology of its kind on the market and we were pleased that the IFT ... of traditional cultured ingredients, creating a natural way to extend the shelf life and ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
Breaking Biology Technology:
Cached News: